Institute for Liver Health

Tucson, Arizona 85711

We've found

3 trials

at this facility

A POC and Dose-Ranging Study of HTD1801 in PSC Patients

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Tucson, AZ

Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Tucson, AZ

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Tucson, AZ

Use our guide to learn which trials are right for you!